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ABSTRACT
Genomic imbalances are a major cause of constitu-
tional and acquired disorders. Therefore, aneuploidy
screening has become the cornerstone of preimplan-
tation, prenatal and postnatal genetic diagnosis, as
well as a routine aspect of the diagnostic workup of
manyacquireddisorders.Recently,arraycomparative
genomic hybridization (array CGH) has been intro-
duced as a rapid and high-resolution method for the
detectionofbothbenignanddisease-causinggenomic
copy-number variations. Until now, array CGH has
been performed using a significant quantity of DNA
derived from a pool of cells. Here, we present an
array CGH method that accurately detects chromo-
somal imbalances from a single lymphoblast, fibro-
blast and blastomere within a single day. Trisomy 13,
18,21andmonosomyX,aswellasnormalploidylevels
ofallotherchromosomes,wereaccuratelydetermined
from single fibroblasts. Moreover, we showed that
a segmental deletion as small as 34 Mb could be
detected. Finally, we demonstrated the possibility to
detect aneuploidies in single blastomeres derived
from preimplantation embryos. This technique offers
new possibilities for genetic analysis of single cells
in general and opens the route towards aneuploidy
screeninganddetectionofunbalancedtranslocations
in preimplantation embryos in particular.
INTRODUCTION
Single-cell genetic analysis at the chromosomal or at the
molecular level is important for basic research as well as
for clinical purposes. An example is its use for aneuploidy
screening of preimplantation embryos obtained by in vitro
fertilization (IVF) (1). Aneuploidy screening of a single cell
would allow addressing basic questions about the chromo-
somal constitution of gametes and the mitotic stability of
chromosomes during early embryogenesis. In the clinic, this
screening could be used to select a single embryo with the
highest chance to implant (1). Several methods, such as ﬂuor-
escent in situ hybridization (FISH) and PCR-based methods,
have been used to analyse chromosomes of a single cell, e.g.
a blastomere biopsied from an 8-cell embryo (2). However,
these approaches can only analyse a small number of genetic
loci in a single cell.
By contrast, genome-wide aneuploidy screening of a single
cell can be performed by comparative genomic hybridization
(CGH) following whole genome ampliﬁcation (WGA) by
degenerated oligonucleotide primed PCR (DOP-PCR) or
linker-adaptor PCR. In this method, two DNA samples, one
obtained by DNA ampliﬁcation from the single cell of inter-
est and one from a reference, are differentially labelled and
hybridized to metaphase spreads derived from cells of a chro-
mosomally normal individual. CGH has been applied to
detect chromosomal copy-number changes within single blas-
tomeres or polar bodies (3) and within single cancer cells (4).
Nonetheless, this method is labour intensive and time con-
suming, which limits its diagnostic potential and hampers
its use in research.
Based on the same principle as metaphase CGH, array
CGH differs in that genomic clones from selected regions
of the genome are spotted on a slide, replacing normal
‘control’ metaphase cells as the target DNA (5,6). This
method has a high-resolution and is amenable to automation.
Thus far, array CGH has mainly been performed using DNA
from large numbers of cells. Attempts to reduce the amount
of DNA needed for array CGH resulted in the accurate
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DNA (7). Recently, Hu et al. (8) have used array CGH for
the detection of chromosomal copy-number variation from
single lymphoblasts and ﬁbroblasts following DOP-PCR
ampliﬁcation. However, no robust results were obtained
since incorrect ratios were sometimes observed for chromo-
somes 2, 4, 9, 11, 17, 22, X and Y.
The major hurdle towards genome-wide single-cell
analysis is the difﬁculty to amplify genomic DNA (gDNA)
without sequence bias. Recently, an isothermal DNA ampli-
ﬁcation method (termed multiple displacement ampliﬁcation,
MDA) has been applied to small DNA samples or single
cells, leading to the synthesis of DNA with limited sequence
representation bias (9–12). Here, we have extended array
CGH technology by making the accurate detection of chro-
mosomal imbalances possible from a single lymphoblast,
ﬁbroblast and blastomere following MDA.
MATERIALS AND METHODS
Cell lines
Epstein–Barr virus (EBV)-transformed lymphoblasts and ﬁbro-
blastswere used to develop the single-cell ampliﬁcation and the
array CGH experiments. Four different ﬁbroblast cell lines
were derived from patients affected by, respectively, trisomy
13, 18, 21 and monosomy X. Fibroblasts containing an intersti-
tial 4q deletion (46,XX,del(4)(q13.1q22.3)) and EBV cells
containing an unbalanced reciprocal translocation involving
chromosomes 14 and X (46,XX,der(X)t(X;14)(q21.3;q23.1))
were used for segmental deletion/duplication detection. Array
CGH experiments were performed using gDNA from the two
cell lines containing a segmental deletion and/or duplication
to deﬁne the exact size of each rearrangement. For the ﬁbro-
blasts containing an interstitial 4q deletion, the size of the
deleted region was 34 Mb corresponding to 39 clones spotted
on the array (from RP11-340A13 to RP11-44P19). For the
EBV cell line, the size of the 14q duplication was 47 Mb cor-
responding to 63 clones (from RP11-62H20 to CTC-820M16)
and the Xq deletion was 58 Mb corresponding to 70 clones
(from RP3-380C13 to RP11-218L14). For each of the six cell
lines, three single cells were ampliﬁed.
Collection and lysis of single cells
Lymphoblasts or ﬁbroblasts were washed three times in
500 ml phosphate-buffered saline. The cells were then
washed in droplets of Ca
2+- and Mg
2+-free medium
[14 mM NaCl, 0.2 mM KCl, 0.04 mM NaH2PO4·2H2O,
5.5 mM glucose, 1.2 mM NaHCO3, 0.02 mM EDTA and
0.01% (w/v) phenol red] supplemented with 15 mg/ml
BSA (Sigma–Aldrich, St Louis, MO) using ﬁne hand-drawn
microcapillaries and were transferred to 200 ml PCR tubes
containing 2.5 ml alkaline lysis buffer (ALB; 200 mM
KOH and 50 mM DTT). An aliquot from the last washing
droplet was taken as a negative control for each collected
single cell. The samples were stored at  80 C for at least
30 min and were further incubated for 10 min at 65 C
prior to the MDA reaction.
Embryo biopsy and disaggregation
Approval for the present study was obtained from the institu-
tional committee of medical ethics (Vrije Universiteit
Brussel) and all donating patients gave informed consent.
Embryo 1 used in this study was from a couple who under-
went preimplantation genetic diagnosis (PGD) for aneuploidy
screening, in which case FISH was performed for chromo-
somes 13, 18, 21, X and Y (13). Embryo 2 was from a couple
who underwent PGD because the mother was a Robertsonian
translocation carrier involving chromosomes 13 and 14, in
which case FISH was performed for chromosomes 13, 14,
18, 21, X and Y. The embryo biopsy was performed the
morning of day 3 after oocyte retrieval. A hole was made
in the zona pellucida (ZP) using two or three laser pulses
of 5–7 ms of a non-contact 1.48 mm diode laser system
(Fertilase, Octax, Herbron, Germany) coupled to a micro-
manipulator on an inverted microscope. Two blastomeres
containing a nucleus were gently aspirated and used for
FISH analysis.
The two embryos diagnosed by FISH as being abnormal
were selected for array CGH analysis. Embryos were brieﬂy
incubated in acidic Tyrode’s solution (pH 2.4) (Vitrolife,
Goteborg, Sweden) to remove the ZP. They were then trans-
ferred to droplets of Ca
2+- and Mg
2+-free medium supple-
mented with 4 mg/ml BSA and gently pipetted to
disaggregate the individual blastomeres. Blastomeres with
a clearly visible nucleus were washed three times in the dis-
sociation medium and transferred using a mouth-piece and
a ﬁnely drawn Pasteur pipette to a 200 ml PCR tube contain-
ing 2.5 ml ALB. An aliquot was taken from the last washing
droplet to serve as a negative control and samples and blanks
were further treated as described for the single lymphoblasts
or ﬁbroblasts.
Whole genome amplification
DOP-PCR ampliﬁcations and MDA with Bst DNA poly-
merase were performed using 1 ng and 100 pg of gDNA
as well as single-cell lysates according to the protocols
described by Hu et al. (8) or Lage et al. (11), respectively.
MDA with f29 DNA polymerase was performed using
the GenomiPhi DNA Ampliﬁcation Kit (GE Healthcare,
Piscataway, NJ). The f29 DNA polymerase was assayed on
100 pg gDNA and single-cell lysates. Prior to the MDA reac-
tion, 2.5 ml of neutralization buffer (0.9 M Tris–HCl, pH 8.3,
0.3 M KCl and 0.2 M HCl) was added to the sample to neut-
ralise ALB. GenomiPhi sample buffer (9 ml) containing
the random hexamer primers was added to the template fol-
lowed by GenomiPhi reaction buffer (9 ml) and GenomiPhi
Enzyme Mix (1 ml). The isothermal ampliﬁcation was per-
formed at 30 C for 3 h and the reaction was stopped upon
incubation at 65 C for 10 min. The MDA products were puri-
ﬁed and resuspended in 50 ml of elution buffer (High Pure
PCR Product Puriﬁcation Kit, Roche, Basel, Switzerland).
All ampliﬁcation products were quantiﬁed with a spectropho-
tometer (Nanodrop ND-1000 spectrophotometer; Nanodrop
Technologies, Rockland, DE) and their quality was evaluated
by PCR for two loci (IVS27AC28.4 and D17S1841).
Although spectrophotometric analysis showed DNA in the
MDA negative controls, no ampliﬁcation product was detec-
ted after locus-speciﬁc PCR in any of the negative controls,
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not originate from contamination with human DNA. The
non-speciﬁc DNA is most probably due to primer-directed
DNA synthesis in the absence of DNA template or to
contamination of the enzyme with bacterial DNA.
Array CGH
For ﬁbroblasts and blastomeres aneuploidy screening, an
array (KUL Human 4K BAC array Aneuploidy screening)
containing 4114 clones [3587 BAC and PAC clones at an
average resolution of 1 Mb (14), 96 additional clones
(RP clones; plate 1, offset A1) for each of the chromosomes
18, 19, 20, 21 and 22 from the Human 32K BAC Re-Array
of CHORI BACPAC Resources (http://bacpac.chori.org/
genomicRearrays.php) and 47 home-made clones (CME)]
was used (15). The products were arrayed in duplicate
using a Lucidea spotter (GE Healthcare).
Array CGH was carried out as described previously (15)
with minor modiﬁcations. Non-ampliﬁed gDNAs from male
and female controls were used as references. Ampliﬁed
(test) and reference DNA samples (300 ng each) were
labelled for 2 h by random primer labelling (BioPrime
Array CGH Genomic Labelling System; Invitrogen, Carls-
bad, CA) using Cy5- and Cy3-labelled dCTPs (GE Health-
care), respectively. Since Cy5-labelled DNA gave higher
intensity signals than Cy3-labelled DNA, a lower amount of
Cy5-labelled DNA was mixed to Cy3-labelled DNA, 2.1 and
4.9 mg, respectively, as calculated from the spectrophoto-
metric values. Labelled probes were combined with 100 mg
Cot-1 DNA (human Cot-1 DNA; Invitrogen) followed by
ethanol precipitation. Resuspension of the pellet was done
in 45 ml hybridization buffer (50% formamide, 10% dextran
sulfate, 0.1% Tween-20, 2· SSC and 10 mM Tris–HCl,
pH 7.5) containing 400 mg yeast tRNA to hybridize a spotting
area of 24 · 60 mm during one night. The slide was blocked
with 50 mg Cot-1 DNA and 300 mg salmon testes DNA
(DNA from salmon testes, Sigma Aldrich) dissolved in
60 ml hybridization buffer.
Experiments using single cells containing a segmental
deletion and/or duplication were performed later. A second
array (KUL Human 4K_2 BAC array Aneuploidy screening)
containing 4013 clones [3475 BAC and PAC clones at an
average resolution of 1 Mb, 96 additional clones (RP clones;
plate 1, offset A1) for each of the chromosomes 18, 19, 20, 21
and 22 from the Human 32K BAC Re-Array of CHORI
BACPAC Resources and 58 home-made clones (CME)]
was developed using a new generation spotter (MicroGrid
II spotter; Genomic Solutions, Cambridge, UK) allowing
higher density arrays. Since the clones were spotted in duplic-
ate on an area two times reduced, ampliﬁed and reference
DNAs, labelled DNAs, buffers and Cot-1 DNA quantities
were also two times reduced.
Since non-speciﬁc DNA was present in the MDA negative
controls, we hypothesized that this DNA would increase the
background noise of each spot. To test this possibility, the
negative control DNA was added to the blocking solution
before hybridization. However, no signiﬁcant higher signal-
to-noise ratios were obtained suggesting that the non-speciﬁc
DNA was not a major cause of array noise and it was omitted
in all subsequent experiments.
Following labelling, hybridization and washing of the
slides, arrays were scanned at 532 and 635 nm using
a GenePix 4000B scanner (Axon Instruments Inc., Foster
City, CA). The scan images were processed with GenePix
Pro 6.0 software. Data analysis was performed using Excel
(Microsoft Corporation, Redmond, WA). In short, spot
intensities were corrected for local background and only
spots with signal intensities at least 1.2-fold above back-
ground were included in the analysis. Since all clones were
printed in duplicate, two ratios of Cy5 to Cy3 ﬂuorescent
intensity (log2 ratio) were calculated for each. For the abnor-
mal cell lines and embryo 1, the abnormalities were known in
advance. So, for each array, normalization of the data was
achieved by subtracting the median of the log2 signal intens-
ities over all the autosomal fragments with measurements
from abnormal chromosomes masked out. Since for embryo
2, the complex patterns of chromosomal imbalances were
not known in advance, all log2 signal intensities were ﬁrst
included in the analysis. Subsequently, mean intensity ratios
corresponding with likely monosomies and trisomies were
masked out.
A mean of all remaining spots of each chromosome was
calculated. The chromosome-speciﬁc threshold of individual
chromosomes (chromosome-speciﬁc threshold), was deter-
mined as the averaged log2 ratio (over each chromosome
individually) of our 18 or 12 experiments (for abnormal
cell lines and blastomeres, respectively) plus or minus three
times the standard deviation of the averaged log2 ratio.
Genomic microarray data
The genomic microarray data discussed in this publication
have been deposited in NCBIs Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through GEO series accession nos GSE3642 and GSE4244.
RESULTS
Optimization of the array CGH procedure
We compared the efﬁcacy of different WGA methods—DOP-
PCR and MDA by Bst or f29 DNA polymerases—to generate
sufﬁcient ampliﬁed DNA with a quality enabling array CGH.
Ampliﬁcation of 100 pg and single lymphoblast gDNA by
f29 DNA polymerase resulted in higher ﬁnal yields com-
pared with DOP-PCR and Bst ampliﬁcations. By assaying
the quality of the ampliﬁed DNA using PCR ampliﬁcation
of microsatellite markers, f29 DNA polymerase proved to
be the most efﬁcient method (16).
As a reference sample, we compared MDA-ampliﬁed
single-cell DNA and non-ampliﬁed gDNA. MDA-ampliﬁed
reference DNA was tested because we expected that
sequence-speciﬁc biases during the ampliﬁcation process
could cause the over- and under-representation of speciﬁc
genomic sequences. The presence of the same over- and
under-representation in both reference and test samples
might average out and reduce intensity ratio imbalances.
For a proof of principle, female DNA was hybridized against
male DNA (sex-mismatch). For the X chromosome, averaged
ratios were 0.77 ± 0.12 with ampliﬁed single-cell DNA
(n ¼ 5) and 0.70 ± 0.12 with non-ampliﬁed gDNA (n ¼ 5)
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e68 Nucleic Acids Research, 2006, Vol. 34, No. 9 PAGE 4 OF 12Figure 1. (A–D) Examplesofsingle-cell array CGHprofilesperformedonaneuploidcelllines. Foreach panel, thex-axisrepresentsthe 22 autosomes, followedby
the X and Y chromosomes. The y-axis marks the log2 mean ratios of all spots of each chromosome. Following f29 DNA polymerase amplification, single cells
containingtrisomy13(A),18(B)and21(C)werehybridizedversusnon-amplifiedgDNAoftheoppositesex,andmonosomicXsinglecell(D)versusnon-amplified
XX gDNA. The checked columns represent the abnormal chromosomes.
Figure 2. Overviewofsingle-cellexperimentsperformedonaneuploidcelllinesandanalysisusingchromosome-specificthreshold.Theclosedcirclesrepresentthe
meanintensityratiosofchromosomes13,18and21ofeachrespectivetrisomycellline.TheopencirclesrepresentthemeanintensityratiosofXandYchromosomes
ofmonosomyXcell line.Thex-axisrepresentsthe22autosomes,theX andY chromosomes.They-axismarksthelog2 meanratioofthe18single-cellexperiments
for each chromosome. The grey columns represent the mean ratios of the 18 experiments of each chromosome plus or minus three times the standard deviation
representing the chromosome-specific threshold.
PAGE 5 OF 12 Nucleic Acids Research, 2006, Vol. 34, No. 9 e68and for the Y chromosome  1.25 ± 0.27 with ampliﬁed
single-cell DNA (n ¼ 5) and  1.63 ± 0.14 with non-
ampliﬁed gDNA (n ¼ 5), whereas averaged ratios for the
autosomes equalled 0. Hence, a lower standard deviation of
the overall autosomal intensity ratios was observed when
using non-ampliﬁed gDNA as a reference (n ¼ 5; 0.84 ±
0.049) compared with ampliﬁed single-cell reference DNA
(n ¼ 5; 1.13 ± 0.045). Therefore, all subsequent array CGH
experiments were conducted with non-ampliﬁed gDNA as
a reference. The overall mean intensity ratios approached 0
for all chromosomes, except for chromosome 19 (n ¼ 10;
 0.17 ± 0.1) and chromosome 22 (n ¼ 10;  0.19 ± 0.3),
a bias reported previously in metaphase CGH analyses from
single cells (17–19). Therefore, the interpretation of chromo-
somes 19 and 22 aneuploidy may be subject to ambiguity,
which need attention in future experiments. To make the
single-cell aneuploidy detection amenable for clinical PGD,
f29 DNA polymerase ampliﬁcation was reduced from 16 to
3 h, labelling from one night to 2 h and hybridization from
two nights to one night without signiﬁcant reduction of the
array CGH quality. All experiments were conducted using
this optimized and fast protocol.
Validation and analysis by aneuploidy screening
in fibroblasts
For each aneuploid cell line (trisomies 13, 18, 21, and mono-
somy X), three single cells were ampliﬁed. Following DNA
ampliﬁcation, all cells showed the expected DNA yields
Table 2. Averaged log2 intensity ratios of the 4q deletion and the normal
chromosomes following array CGH on single fibroblasts
Chromosome del(4q)_cell1 del(4q)_cell2 del(4q)_cell3
1 0.06  0.05 0.03
2 0.05 0.09 0.03
3 0.12 0.14 0.11
4
a  0.23  0.03  0.11
4
b  0.66  0.56  0.58
4
c 0.14 0.26 0.10
5 0.01 0.05 0.04
6 0.04 0.05 0.13
7 0.01 0.03 0.05
8 0.26 0.12 0.15
9  0.10  0.01 0.11
10 0.05  0.02  0.06
11 0.07  0.14  0.09
12  0.02  0.01 0.03
13 0.04 0.04 0.00
14 0.08 0.08 0.15
15 0.14  0.10 0.08
16  0.06  0.17 0.07
17  0.22  0.32 0.01
18 0.02 0.09 0.14
19  0.36  0.32  0.32
20  0.16  0.34  0.04
21 0.00 0.09  0.12
22  0.39  0.38  0.23
X 0.87 0.86 0.91
Y  2.01  2.00  1.96
gDNA XY XY XY
4
arepresenttheregionfromthesubtelomere4ptothecentromericbreakpointof
thedeletion(59.8Mb),4
bcorrespondtothe4qdeletion(34Mb)and4
ctheregion
fromthedistalbreakpointofthedeletiontothesubtelomere4q(97.6Mb);gDNA:
sex chromosomes of the reference gDNA. Ratios exceeding the thresholds are
shown in bold pinpointing potential (segmental) trisomies and monosomies.
Figure 3. (A–C)Examplesofsingle-cellarrayCGHprofilesperformedoncell
lines containing a segmental deletion and/or duplication. (A) Following f29
DNA polymerase amplification, single cells containing an interstitial 4q dele-
tion were hybridized versus non-amplified gDNA of the opposite sex. The
y-axis marks the log2 mean ratios of all spots of each chromosome. The x-axis
represents the 22 autosomes, followed by the X and Y chromosomes. Chromo-
some 4 was divided in three regions: 4
a represented the region from the sub-
telomere 4p to the centromeric breakpoint of the deletion (59.8 Mb), 4
b
corresponded to the 4q deletion (34 Mb) and 4
c the region from the distal
breakpoint of the deletion to the subtelomere 4q (97.6 Mb). The deleted region
(4
b) showed the expected log2 mean ratio. (B and C) Following f29 DNA
polymerase amplification, single cells containing an unbalanced reciprocal
translocation involving chromosomes X and 14 were hybridized versus non-
amplified46,XXand46,XYgDNA.They-axismarksthelog2meanratiosofall
spots of each chromosome. Chromosome 14 was divided in two regions: 14
a
represented the region from the centromere to the breakpoint of the transloca-
tion(59.4Mb),14bcorrespondedtothe14qduplication(47Mb).Chromosome
X was divided in two regions: X
a represented the region from the subtelomere
Xp to the breakpointof the translocation(59.7 Mb) and X
b corresponded to the
Xq deletion. When hybridized versus female gDNA (B), a deletion of X
b was
expected, whereas hybridised versus male gDNA (C), a log2 mean ratio corre-
sponding to a duplication of X
a was expected. The checked columns represent
the 4q- and the Xq-deleted regions and the 14q-duplicated region.
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(IVS27AC28.4 and D17S1841) were performed on all ampli-
ﬁed cells. Speciﬁc ampliﬁcation was obtained in all ampliﬁed
single-cell DNA with the D17S1841 marker and in 10 out of
12 cells with the IVS27AC28.4 marker.
Sex-mismatch array CGH experiments were conducted on
ampliﬁed DNA samples obtained from each cell. We ana-
lysed our array CGH data obtained from the abnormal cell
lines (n ¼ 18; 12 experiments performed on aneuploid single
cells and 6 on single cells containing a segmental deletion
Table 3. Averaged log2 intensity ratios of the 14q duplication, the Xq deletion and the normal chromosomes following array CGH on single EBV cells
Chromosome der(X)_cell1 der(X)_cell2 der(X)_cell3 der(X)_cell1 der(X)_cell2 der(X)_cell3
1 0.01  0.08  0.02  0.01  0.08  0.05
2 0.08 0.11 0.10 0.08 0.11 0.11
3 0.07 0.07 0.06 0.08 0.05 0.06
4  0.01 0.09 0.08  0.01 0.08 0.06
5 0.07  0.05 0.15 0.07  0.03 0.16
6 0.00 0.02 0.08 0.01 0.02 0.10
7 0.03  0.06 0.02 0.02  0.05 0.02
8 0.01 0.12 0.06 0.01 0.10 0.03
9  0.02 0.15  0.06  0.03 0.16  0.08
10 0.02  0.09 0.04 0.01  0.09 0.07
11 0.00  0.05  0.17  0.01  0.05  0.17
12 0.06 0.05 0.01 0.07 0.04 0.01
13 0.04 0.10 0.03 0.04 0.12 0.04
14
a 0.15  0.01 0.23 0.16 0.00 0.23
14
b 0.47 0.38 0.63 0.48 0.37 0.67
15 0.04 0.07 0.09 0.05 0.07 0.11
16  0.01 0.03  0.06  0.02 0.05  0.06
17  0.07  0.20  0.15  0.07  0.17  0.14
18  0.04 0.06 0.03  0.04 0.06 0.02
19  0.17  0.19  0.28  0.18  0.16  0.32
20 0.05 0.02  0.25 0.05 0.03  0.28
21  0.02 0.02  0.10 0.00 0.02  0.10
22  0.10  0.21  0.41  0.12  0.21  0.45
X
a 0.73 1.00 0.93  0.03 0.20 0.22
X
b 0.00  0.03  0.09  0.91  0.80  1.07
Y  1.89  2.14  1.79 0.05 0.05 0.17
gDNA XY XY XY XX XX XX
14
arepresenttheregionfromthecentromeretothebreakpointofthetranslocation(59.4Mb);14
bcorrespondtothe14qduplication(47Mb);X
arepresenttheregion
fromthesubtelomereXptothebreakpointofthetranslocation(59.7Mb);X
bcorrespondtotheXqdeletion;gDNA,sexchromosomesofthereferencegDNA.Ratios
exceeding the thresholds are shown in bold pinpointing potential (segmental) trisomies and monosomies.
Table 4. Averaged log2 intensity ratios of all chromosomes following array CGH on single blastomeres
Chromosome E1_cell1 E1_cell2 E1_cell3 E1_cell4 E1_cell5 E1_cell6 E2_cell1 E2_cell2 E2_cell3 E2_cell4 E2_cell5 E2_cell6
1 0.09 0.03  0.06  0.12  0.09  0.05  0.67  0.67  0.63 0.51 0.40  0.87
2 0.12  0.06 0.03 0.07 0.16 0.15  0.10 0.06  0.03  0.21  0.04 0.06
3 0.04 0.15 0.16 0.13 0.14 0.12  0.70  0.52  0.67 0.27 0.34  0.80
4  0.04 0.12 0.11 0.14 0.07 0.08  0.59  0.62  0.68 0.05 0.20  0.72
5  0.08 0.23 0.16 0.12 0.03 0.07 0.09 0.10  0.03  0.09  0.02  0.27
6 0.04 0.10 0.03 0.03 0.03 0.03 0.04  0.18 0.02  0.14  0.12  0.06
7  0.02 0.06 0.05 0.05 0.05 0.05  0.08 0.02 0.04  0.11  0.21 0.05
8 0.05  0.07 0.16 0.20 0.15 0.14 0.01  0.11  0.05  0.05  0.04 0.10
9 0.04 0.05 0.22 0.07 0.00 0.05  0.23  0.01  0.01  0.05  0.16  0.20
10 0.03 0.10 0.19 0.21  0.05  0.07 0.15  0.24 0.06  0.07 0.01 0.05
11  0.06 0.11 0.06 0.02 0.01  0.02 0.14 0.12 0.10 0.09  0.12 0.06
12  0.02 0.03 0.17 0.18 0.00  0.03 0.25 0.01 0.00  0.04  0.09 0.17
13  0.12 0.04 0.03  0.11  0.26  0.20  0.18  0.09  0.82  0.20  0.27  1.08
14 0.10  0.04 0.14 0.17 0.01  0.02 0.08 0.02  0.65  0.16  0.05 0.11
15 0.25 0.04  0.03  0.05  0.04  0.05 0.19 0.13 0.16  0.15 0.01  0.08
16 0.04  0.22  0.08  0.11  0.06  0.02 0.17  0.03 0.02  0.09 0.00  0.05
17  0.18 0.06 0.08  0.01  0.07  0.10 0.18 0.29  0.04 0.12 0.18 0.16
18 0.16 0.06  0.03  0.01 0.06 0.07  0.16 0.18  0.04 0.01 0.06 0.05
19  0.16  0.03  0.08  0.17  0.34  0.29 0.06 0.24 0.35 0.08 0.17 0.19
20  0.12  0.08  0.02 0.03  0.15  0.14 0.00 0.28 0.20 0.15 0.11 0.12
21  0.02  0.16  0.10  0.20  0.14  0.15  0.80  0.67  0.57 0.30 0.03  0.93
22  0.07 0.08  0.21  0.20  0.24  0.24  0.03 0.24  0.02 0.04 0.10 0.24
X  0.76  0.53  0.55  0.78  0.73  0.69  0.81  0.60  0.57  0.75  0.62  0.67
Y  0.05  0.09  0.05 0.05  0.07  0.14 1.31 1.48 1.58 1.57 1.03 1.25
gDNA XX XX XX XX XX XX XX XX XX XX XX XX
gDNA. sex chromosomes of the reference gDNA. Ratios exceeding the thresholds are shown in bold pinpointing potential trisomies and monosomies.
PAGE 7 OF 12 Nucleic Acids Research, 2006, Vol. 34, No. 9 e68and/or duplication) using a chromosome-speciﬁc threshold as
described in Materials and Methods. Using the averaged
log2 ratio (over each chromosome individually) of our
18 experiments plus or minus three times the standard devia-
tion of the averaged log2 ratio, sex chromosome ploidy levels,
as well as all expected autosomal abnormalities were accu-
rately identiﬁed (Table 1; Figure 1A–D). Overall, neither
false negatives nor false positives were detected (Figure 2).
Segmental deletion/duplication detection on
EBV lymphoblasts and fibroblasts
Array CGH experiments were performed on ﬁbroblasts con-
taining an interstitial 4q deletion and lymphoblasts containing
a 14q duplication and a Xq deletion. For each cell line, three
single cells were ampliﬁed. Following DNA ampliﬁcation, all
cells showed the expected DNA yields (n ¼ 6; 2.36 mg±
0.12). Two different locus-speciﬁc PCRs (IVS27AC28.4
and D17S1841) were performed on all ampliﬁed cells. Spe-
ciﬁc ampliﬁcation was obtained in all ampliﬁed single-cell
DNA with both the D17S1841 and the IVS27AC28.4
markers.
Sex-mismatch array CGH experiments were conducted on
ampliﬁed DNA samples obtained from each of the three sin-
gle cells containing an interstitial 4q deletion. Using the
chromosome-speciﬁc threshold obtained from our 18 experi-
ments, sex chromosome and autosome ploidy levels were
accurately identiﬁed with no false negative and no false pos-
itive results. Averaging the 39 clones within the chromosome
4q deleted region enabled the accurate detection of the dele-
tions (Table 2 and Figure 3A). For each of the three ampliﬁed
single-cell DNA of the unbalanced reciprocal translocation
involving chromosomes 14 and X, male and female gDNA
were used as references. Sex chromosome and autosome
ploidy levels were accurately identiﬁed (Table 3). Averaging
intensity ratios of the 63 clones within the chromosome
14 duplicated region enabled the accurate detection of the
duplications in the three replicate experiments (Table 3 and
Figure 3B and C). When male or female gDNA were used
as a reference, the averaged log2 mean ratio of the Xq deleted
region was  0.04 or  0.93, respectively, close to the theor-
etical expected values of 0 or minus 1 (Figure 3B and C).
Interestingly, the log2 mean ratios of chromosomes 1–22
were highly similar when the same single-cell ampliﬁed
DNA was used for the two experiments using female and
male DNA as a reference, respectively. Hence, array CGH
intensity ratio proﬁles were very reproducible (Table 3).
Aneuploidy screening in human blastomeres
DNA from blastomeres from two 8 cell-stage embryos was
ampliﬁed with f29 DNA polymerase. All cells yielded the
expected amount of DNA (n ¼ 12; 2.53 mg ± 0.27). To verify
the quality of this ampliﬁed single-cell DNA, two different
locus-speciﬁc PCRs (D17S1841 and IVS27AC28.4) were
performed and speciﬁc ampliﬁcation was obtained for at
least one of these two markers. The D17S1841 marker was
ampliﬁed in 11 out of 12 single-cells and the IVS27AC28.4
marker in all ampliﬁed single-cells.
By FISH, embryo 1 was diagnosed as monosomic for chro-
mosome X, while chromosomes 13, 18 and 21 were normal.
Array CGH on each of the six ampliﬁed blastomeres
conﬁrmed monosomy X (n ¼ 6;  0.67 ± 0.1) with no addi-
tional abnormalities (Tables 4 and 5 and Figure 4A).
By FISH, embryo 2 was diagnosed as trisomic for chromo-
some 21, while the other analysed chromosomes were normal
(13, 14, 18, X and Y). In contrast to the FISH results, array
CGH analysis of six individual blastomeres showed complex
patterns of chromosomal imbalances in the different cells
(Tables 4 and 5 and Figure 4B–E). Among these abnormalit-
ies, a monosomy 21 was observed in four blastomeres while
two others were normal for chromosome 21.
Because of the discrepancy between FISH and array CGH
results obtained on blastomeres from embryo 2, locus-speciﬁc
PCR analyses were performed on ampliﬁed blastomere DNA.
In case of monosomy, a single allele for all polymorphic
markers of this chromosome has to be detected while, in
case of disomy, two different alleles have to be detected.
The ampliﬁed DNAs of 10 blastomeres were analysed
using 5 microsatellite markers located across chromosome 21
(Table 6). These ﬁve markers were heterozygous in embryo
2. Two alleles for at least four out of the ﬁve markers were
observed in each of the six ampliﬁed blastomeres disomic
for chromosome 21 by array CGH. These ﬁndings were con-
sistent with disomy 21 in these blastomeres. For the four blas-
tomeres from embryo 2 identiﬁed as monosomic for
chromosome 21 by array CGH, only a single allele was detec-
ted for all ﬁve markers. Considering the low allele drop-out
rate (i.e. the failure of ampliﬁcation of one allele) of each
marker, this was consistent with the presence of monosomy
21 in these blastomeres and conﬁrmed the array CGH results.
Because of the limited availability of ampliﬁed DNA, the
other chromosomal monosomies could not be further
investigated.
DISCUSSION
We have demonstrated the feasibility of performing single-
cell aneuploidy screening by array CGH following MDA.
Both sex chromosome and autosomal aneuploidies were
accurately detected in different human cell types using
a rapid array CGH protocol. In addition to be able to detect
whole-chromosome copy-number changes, the method was
equally capable of detecting segmental deletions/duplications.
The ability to detect a segmental deletion/duplication is
related to the standard deviation of the signal intensity ratios,
to the size of the duplicated or deleted chromosomal region,
and to the statistical signiﬁcance the experiment needs
(Supplementary Data). At a signiﬁcance level of 95% and
Table5.SummaryoftheFISHversusarrayCGHresultsonsingleblastomeres
Stage FISH results Array CGH results Interpretation
Embryo 1 8 cells  X (2) 45,X (6) Monosomy X
embryo
Embryo 2 8 cells +21,XY (2) 40,XY, 1, 3, 4,
 13, 14, 21 (1);
41,XY, 1, 3, 4,
 13, 21 (1);
42,XY, 1, 3, 4,
 21 (2); 47,XY,+1 (2)
Chaotic embryo
The number of cells analysed and identified with the aberration is shown in
parentheses.
e68 Nucleic Acids Research, 2006, Vol. 34, No. 9 PAGE 8 OF 12Figure 4. (A–D) Examples of single-cell array CGH profiles performed on blastomeres. For each, the x-axis represents the 22 autosomes, followed by the X and
Y chromosomes. The y-axis marks the log2 mean ratios of all spots of each chromosome. The checked columns represent the abnormal chromosomes. Following
f29 DNA polymerase amplification, (A) one blastomere of embryo 1 was hybridized versus non-amplified female gDNA, (B and D) three blastomeres of embryo
2 versus non-amplified female gDNA. (E) Overview of single-cell experiments performed on embryo 2. The closed circles represent the mean intensity ratios of
abnormal chromosomes identified. The x-axis represents the 22 autosomes, the X and Y chromosomes. The y-axis marks the log2 mean ratios of the 12 single-cell
experiments of each chromosome. The grey columns represent the mean ratios of the 12 experiments of each chromosome plus or minus three times the standard
deviation used for the chromosome-specific threshold.
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experiments of 0.8, we can establish that the intensity ratio
changes in 60 clones will be detected without a priori know-
ledge which imbalances might be expected. A number of dif-
ferent methods allowing the detection of segmental deletion/
duplication have been described elsewhere (20). However,
with a priori knowledge about the expected imbalance, even
smaller deleted and duplicated fragments can be reliably
detected. Here, we demonstrated the accurate detection of
the del(4q) and the unbalanced translocation t(X;14) with
deletion sizes of 34 and 58 Mb, respectively and a duplication
of 47 Mb. Often, such a priori knowledge is available. For
example, PGD can be offered to couples where one of the
partners is carrier of a balanced translocation. In these
instances, the size of the unbalanced meiotic products are
known in advance and will be detected by this method.
Array CGH to detect such imbalances would thus provide
a universal platform, whereas different FISH probes have to
be optimized for each translocation. This can be especially
labour intensive for complex translocations (21). Theoretic-
ally, chromosome tiling path arrays containing one clone
every 100 kb will detect genomic imbalances as small as
6 Mb in size. Improvements in the ampliﬁcation and array
CGH procedure are likely to further increase the resolution
of the technology.
For metaphase CGH, as well as for array CGH, several
statistical methods have been proposed for the objective inter-
pretation of CGH proﬁles, but none of them were completely
satisfactory (22–24). In the present study, three times the
standard deviation of the averaged chromosomal intensity
ratio was used as a cut-off and, as a consequence, theoretic-
ally 0.3% false positives were expected. Experimentally, we
observed no false positives analysing 423 chromosomes (i.e.
24 chromosomes in 18 single-cell experiments after removing
9 chromosomes containing a segmental deletion/duplication)
(0/423 ¼ 0%; 95% CI 0–0.7%). From this, it is clear that
<0.7% false positive will occur per chromosome. Analysis
of more cells may further reduce this maximum value and
the theoretical value of 0.3% per analysed chromosome
could be approached.
A number of studies showed that normal developing
embryos exhibit a high number of numerical aberrations and
a high degree of mosaicism at the 8-cell stage (13,25–30).
Some of them appear to be karyotypically ‘chaotic’ with
almost every cell having a different chromosome abnormal-
ity (28). About 20% of the embryos with bad morphology
are ‘chaotic’ (31). The patient-related occurrence of chaotic-
ally dividing embryos has been observed, i.e. some patients
had ‘chaotic’ embryos in repeated cycles, whereas other
patients were completely free of this type of anomaly
(18,28,30,32). In this study, array CGH analysis of six indi-
vidual blastomeres of embryo 2 showed complex patterns of
chromosomal imbalances in the different cells, leading to
the diagnosis of ‘chaotic’ embryo. Five other embryos from
this couple were also diagnosed as ‘chaotic’ by FISH. There-
fore, the array CGH results of embryo 2 were not surprising.
The ability to detect chromosomal imbalances in a single
cell will have several applications. Here, we applied single-
cell aneuploidy screening for the detection of chromosomal
imbalances in preimplantation embryos. From the analysis
of two different embryos, we showed that chromosomal
aneuploidies can be detected in single blastomeres. These
ﬁndings open the route towards PGD for aneuploidy screen-
ing (PGS) in a clinical setting. In contrast to metaphase CGH,
our approach can detect aneuploidies in blastomeres within
a single day and is amenable to automatic processing and
data interpretation. The advantage of array CGH over FISH
is that the copy number of all chromosomes can be determ-
ined. It was hypothesized that PGS would enable selection
of chromosomally normal embryos and hence, would
improve the implantation rate (1). Current retrospective and
prospective studies (13,33) to test this hypothesis have been
hampered by the limited number of chromosomes (5–9)
that could be analysed by FISH and therefore, current data
are only partial. Interestingly, in one of the two embryos,
we identiﬁed chromosomal imbalances not detected by the
standard FISH analysis for PGD, suggesting the need for
full genome aneuploidy screening to test whether embryo
selection enhances implantation rates. Moreover, we have
shown that array CGH can also be used in PGD for chromo-
somal aberrations, such as reciprocal or Robertsonian translo-
cations, thus obviating the often time consuming optimization
of speciﬁc FISH probes.
In conclusion, we have optimized array CGH to detect
chromosome copy-number changes in single cells and dem-
onstrate its applicability in PGD. The method is likely to
open up novel diagnostic opportunities, such as the analysis
of cancer or fetal cells circulating in the peripheral blood or
the analysis of a small number of microdissected tumor cells.
Moreover, single-cell genomic analysis will provide new
insights to discern the molecular changes that underlie cancer
progression and invasiveness (34).
Table 6. Short Tandem Repeat (STR) analysis showing consistent results with the presence of monosomy 21 observed in the four blastomeres of embryo 2
STR marker
a Blastomeres interpreted as monosomic for chromosome 21 by array CGH
(n ¼ 4)
Blastomeres
b interpreted as disomic for
chromosome 21 by array CGH (n ¼ 6)
Heterozygous Hemizygous No amplification Heterozygous Allele drop-out
D21S1257 0 4 0 6 0
D21S1259 0 4 0 5 1
D21S1904 0 4 0 5 1
D21S1256 0 4 0 4 2
D21S1260 0 2 2 4 2
aSTR analysis of two blastomeres of embryo 2 (interpreted as disomic for chromosome 21 by array CGH) demonstrated informativity for all five markers for this
embryo.
bTwo from embryo 2 and four blastomeres from an additional embryo.
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